Last Posted: May 16, 2023
- Association of Genetic Variants of HLA-DQA1 with Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors.
Takeshi Ozeki, et al. The Journal of investigative dermatology 2023 0
- Relationship between pemphigus and American tegumentary leishmaniasis: insights from serological and genetic profiles.
Walsh Priscilla, et al. Transactions of the Royal Society of Tropical Medicine and Hygiene 2017 0 (8) 345-353
- Risk of venous thromboembolism in patients with bullous pemphigoid: A systematic review and meta-analysis.
Ungprasert Patompong, et al. Indian journal of dermatology, venereology and leprology 2017 0 (1) 22-26
- Haplotypes of ABCB1 1236C?>T (rs1128503), 2677G?>T/A (rs2032582), and 3435C?>T (rs1045642) in patients with bullous pemphigoid.
Rychlik-Sych Mariola, et al. Archives of dermatological research 2018 0 (6) 515-522
- Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans.
Russlies Juliane, et al. Frontiers in immunology 2019 0 2200
- Genetic susceptibility of dipeptidyl Peptidase-4 inhibitor associated bullous pemphigoid in Chinese patients with type 2 diabetes.
Shi Mai, et al. Journal of the European Academy of Dermatology and Venereology : JEADV 2022 0 (3) e375-e377
- A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?
Amber K T, et al. HLA 2017 0 (3) 127-134
- Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers.
Casajús Ana, et al. Advances in therapy 2022 0 (4) 1743-1753
- Imputation of the major histocompatibility complex region identifies major independent variants associated with bullous pemphigoid and dermatomyositis in Han Chinese.
Fan Wencheng, et al. The Journal of dermatology 2022 6
- IL-13 Genetic Susceptibility to Bullous Pemphigoid: A Potential Target for Treatment and a Prognostic Marker.
Wang Yiman, et al. Frontiers in immunology 2022 0 824110
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 09, 2023
- Content source: